Atg5 knockdown also led to reduced cellular proliferation, but not to the same extent as seen following miR-9-3p transfection with an observed reduction in the number of viable cells by 12.6% (TT cells; P = 0.04) and 2% (MZ-CRC-1 cells; P = 0.43), respectively. Here, ATG5 is linked to colorectal carcinoma.